Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Cash Flows From Operating Activities | |||||
Net Income | -25,005 | -2,515 | -8,041 | -4,995 | -3,301 |
Depreciation Amortization | 338 | 436 | 546 | 216 | 271 |
Accounts receivable | -2,024 | 172 | -264 | -28 | 108 |
Accounts payable and accrued liabilities | -11 | 21 | 234 | 194 | -392 |
Other Working Capital | -3,320 | 302 | -533 | -796 | -628 |
Other Operating Activity | 32,370 | 2,189 | 3,732 | 435 | 780 |
Operating Cash Flow | $2,348 | $605 | $-4,327 | $-4,974 | $-3,162 |
Cash Flows From Investing Activities | |||||
PPE Investments | -500 | -144 | -1,257 | -1,418 | -585 |
Purchase Of Investment | -6,000 | N/A | N/A | -1,410 | -7,952 |
Sale Of Investment | N/A | N/A | 1,650 | 7,067 | 402 |
Investing Cash Flow | $-6,500 | $-144 | $393 | $4,240 | $-8,135 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | 1,000 | 3,000 | N/A | N/A |
Debt Repayment | N/A | -24 | N/A | N/A | N/A |
Common Stock Issued | 20,508 | 3,978 | 279 | 369 | 13,680 |
Dividend Paid | -436 | -106 | N/A | N/A | N/A |
Other Financing Activity | 8,074 | -52 | -112 | 0 | 0 |
Financing Cash Flow | $28,146 | $4,796 | $3,167 | $369 | $13,680 |
Beginning Cash Position | 6,663 | 1,406 | 2,173 | 2,539 | 156 |
End Cash Position | 30,657 | 6,663 | 1,406 | 2,173 | 2,539 |
Net Cash Flow | $23,994 | $5,257 | $-767 | $-366 | $2,383 |
Free Cash Flow | |||||
Operating Cash Flow | 2,348 | 605 | -4,327 | -4,974 | -3,162 |
Capital Expenditure | -500 | -144 | -1,257 | -1,418 | -590 |
Free Cash Flow | 1,848 | 461 | -5,584 | -6,392 | -3,752 |